Breast lumps are a massive topic for the UKMLA AKT, and honestly, they're one of those areas where having a solid "mental algorithm" makes life so much easier. Let's start by pulling up some key lessons to give us a good foundation.

The Triple Assessment is the gold standard for evaluating any suspicious breast lump. The goal is to achieve 100% diagnostic accuracy by combining three different modalities. If any one of these is suspicious, you proceed as if it's malignant until proven otherwise.

1. Clinical Assessment: A thorough history (risk factors, cycle relation) and bilateral breast examination (including axillary lymph nodes).
2. Imaging:
   • Age < 35: Ultrasound is preferred because younger breast tissue is often too dense for mammography.
   • Age ≥ 35: Mammography is the primary tool, often supplemented by ultrasound.
3. Tissue Sampling:
   • Core Biopsy: The preferred method as it preserves tissue architecture (allows differentiation between in situ and invasive cancer).
   • Fine Needle Aspiration (FNA): Mostly used for cysts or sometimes for axillary nodes, but less common for the primary lump now.

Let me find a visual to help you visualize what we're looking for during the imaging phase.

That mammogram really highlights the difference between normal fibroglandular tissue and a suspicious, high-density mass.

This image shows a classic "spiculated" mass on the right, which is highly suggestive of malignancy.

When radiologists look at these images, they use the BI-RADS (Breast Imaging-Reporting and Data System) to standardize their findings. It's a 0-6 scale that tells the clinician exactly how worried they should be.

In the UK, the management pathway is heavily driven by the NICE 2-week wait (2WW) referral criteria. If a patient meets these criteria, they must be seen by a specialist within 14 days for that triple assessment we talked about.

NICE 2WW Referral Criteria (High Yield!):

• Age ≥ 30 with an unexplained breast lump (with or without pain).
• Age ≥ 50 with unilateral nipple symptoms (discharge, retraction, etc.).
• Skin changes (e.g., peau d'orange) or a suspicious axillary lump.

Once they're in the clinic, the pathway usually follows a very logical flow from assessment to diagnosis. Let me map that out for you with a flowchart.

That flowchart really sums up the whole process! The key is that Triple Assessment is the core of the diagnostic workup, and the BI-RADS score helps guide the next steps.

One thing to keep in mind for the UKMLA is the difference between a fibroadenoma (common in younger women, "breast mouse," mobile, firm) and a breast cyst (common in peri-menopausal women, often fluctuates with the menstrual cycle).

Since we've covered a lot of ground, would you like to try a quick game to see if you can categorize different breast lump features? It's a great way to lock in the differences between benign and malignant findings!